Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 5Recruiting 3Not yet recruiting 3Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Thyroid Neoplasms 1Hypothyroidism 1Brain Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Thyroxine × Clear all
NCT02946918 2020-12-01

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

University of Texas Southwestern Medical Center

Phase 4 Terminated
14 enrolled 9 charts
Head & Neck

Thyroid Neoplasms

NCT00488644 2013-06-24

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Terminated
12 enrolled 3 charts
CNSHead & Neck

Brain Neoplasms, Hypothyroidism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡